National Institute of General Medical Sciences; Notice of Closed Meetings, 13088-13089 [2024-03404]

Download as PDF 13088 Federal Register / Vol. 89, No. 35 / Wednesday, February 21, 2024 / Notices Agenda: To review and evaluate the Pediatrics and Critical Care Medicine Department, Emerging Pathogens Section. Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 (Virtual). Name of Committee: Board of Scientific Counselors of the NIH Clinical Center. Date: March 26, 2024. Time: 11:00 a.m. to 12:30 p.m. Agenda: To review and evaluate the Pediatrics and Critical Care Medicine Department, Emerging Pathogens Section. Place: Clinical Center, 10 Center Drive, Bethesda, MD 20892 (Virtual). Contact Person: Ronald Neumann, M.D., Deputy Scientific Director, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, 301–496–6455, rneumann@cc.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Patricia B. Hansberger, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03441 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Center for Inherited Disease Research (CIDR). Date: March 7, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Human Genome Research Institute, National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892. VerDate Sep<11>2014 17:43 Feb 20, 2024 Jkt 262001 Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, 6700B Rockledge Drive, MSC 6908, Rockville, MD 20892, (301) 402–8739, pozzattr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: February 15, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03520 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Preteen Suicide Prevention. Date: March 19, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Evon Abisaid, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Rockville, MD 20852, (301) 827–0399, ereifejes@mail.nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Precision HIV Health: Integrating Data and Implementation Science. Date: March 20, 2024. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Jasenka Borzan, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Mental Health, Neuroscience Center, 6001 Executive Blvd., Bethesda, MD 20892, 301– 435–1260, jasenka.borzan@nih.gov. Name of Committee: National Institute of Mental Health Special Emphasis Panel; Pathway to Independence Awards (K99/R00). Date: March 22, 2024. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: David W. Miller, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, National Institutes of Health, Neuroscience Center, 6001 Executive Blvd., Bethesda, MD 20892–9608, 301–443–9734, millerda@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: February 15, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03522 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of NIH Pathway to Independence Award (K99/R00) Applications. Date: March 11–12, 2024. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Lee Warren Slice, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical E:\FR\FM\21FEN1.SGM 21FEN1 khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 89, No. 35 / Wednesday, February 21, 2024 / Notices Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, Maryland 20892, 301–435–0807, slicelw@ mail.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of IDeA Clinical and Translational Research Development (CTR– D) Award. Date: March 20–21, 2024. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Nina Sidorova, Ph.D. Scientific Review Officer, Scientific Review Branch, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN18–01, Bethesda, Maryland 20892, 301–594–3663, sidorova@nigms.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of IDeA Clinical and Translational Research Network (CTR–N). Date: March 22, 2024. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Room 3AN18D, Bethesda, Maryland 20892, 301–594–2849, dunbarl@mail.nih.gov. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of Support for Research Excellence—First Independent Research (SuRE-First) Award. (R16) Date: March 25–26, 2024. Time: 9:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, Maryland 20892 (Virtual Meeting). Contact Person: Jason M. Chan, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of General Medical Sciences, 45 Center Drive, MSC 6200, Bethesda, Maryland 20892, 301–594–3663, jason.chan2@nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: February 14, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03404 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 17:43 Feb 20, 2024 Jkt 262001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Healthcare Decision Making. Date: March 18, 2024. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Janetta Lun, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Bldg. Suite 213, (301) 496–9666, janetta.lun@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: February 14, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03403 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, Maximizing Opportunities for Scientific and Academic Independent Careers, February 23, 2024, 1:00 p.m. to 4:00 p.m., National Institutes of Health, 6705 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on January 18, 2024, FR Document No. 2024–01294, 89 FRN 4614. PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 13089 This notice is being amended to change the SRO/Executive Secretary and Contact Person. Nawazish Naqvi, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 208–Y, Bethesda MD 20817, 301–451–6992, nawazish.naqvi@nih.gov. The meeting is closed to the public. Dated: February 15, 2024. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–03521 Filed 2–20–24; 8:45 am] BILLING CODE 4140–01–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 731–TA–873–875, 878– 880, and 882 (Fourth Review)] Steel Concrete Reinforcing Bar From Belarus, China, Indonesia, Latvia, Moldova, Poland, and Ukraine; Notice of Commission Determination To Conduct Full Five-Year Reviews United States International Trade Commission. ACTION: Notice. AGENCY: The Commission hereby gives notice that it will proceed with full reviews pursuant to the Tariff Act of 1930 to determine whether revocation of the antidumping duty orders on steel concrete reinforcing bar from Belarus, China, Indonesia, Latvia, Moldova, Poland, and Ukraine would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time. A schedule for the reviews will be established and announced at a later date. DATES: February 5, 2024. FOR FURTHER INFORMATION CONTACT: Lawrence Jones (202–205–3358), Office of Investigations, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Hearingimpaired persons can obtain information on this matter by contacting the Commission’s TDD terminal on 202– 205–1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202–205–2000. General information concerning the Commission may also be obtained by accessing its internet server (https:// www.usitc.gov). The public record for these reviews may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. SUMMARY: E:\FR\FM\21FEN1.SGM 21FEN1

Agencies

[Federal Register Volume 89, Number 35 (Wednesday, February 21, 2024)]
[Notices]
[Pages 13088-13089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of NIH Pathway to 
Independence Award (K99/R00) Applications.
    Date: March 11-12, 2024.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Lee Warren Slice, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical

[[Page 13089]]

Sciences, National Institutes of Health, 45 Center Drive, Room 
3AN12, Bethesda, Maryland 20892, 301-435-0807, [email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of IDeA Clinical and 
Translational Research Development (CTR-D) Award.
    Date: March 20-21, 2024.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Nina Sidorova, Ph.D. Scientific Review Officer, 
Scientific Review Branch, National Institute of General Medical 
Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, 
Room 3AN18-01, Bethesda, Maryland 20892, 301-594-3663, 
[email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of IDeA Clinical and 
Translational Research Network (CTR-N).
    Date: March 22, 2024.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Lisa A. Dunbar, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
MSC 6200, Room 3AN18D, Bethesda, Maryland 20892, 301-594-2849, 
[email protected].

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Review of Support for Research 
Excellence--First Independent Research (SuRE-First) Award. (R16)
    Date: March 25-26, 2024.
    Time: 9:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
General Medical Sciences, Natcher Building, 45 Center Drive, 
Bethesda, Maryland 20892 (Virtual Meeting).
    Contact Person: Jason M. Chan, Ph.D., Scientific Review Officer, 
Scientific Review Branch, National Institute of General Medical 
Sciences, 45 Center Drive, MSC 6200, Bethesda, Maryland 20892, 301-
594-3663, [email protected].

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: February 14, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03404 Filed 2-20-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.